Nine Axinn Attorneys Named to Capital Pro Bono Honor Roll
May 1, 2024
Ten Axinn attorneys have been named to the DC Courts 2023 Capital Pro Bono Honor Roll, which annually recognizes members of the DC Bar who performed 50 hours or more of pro bono legal services. Those who performed over 100 hours received the High Honors distinction. For 2023, 5,032 attorneys registered for the Honor Roll and the members hail from 166 firms, solo practices, federal and local government agencies, corporations, associations, and public interest organizations.
High Honors
- Francis Morrison
- Ricardo Camposanto
- Sandhya Taneja
Honors
- Ted Mathias
- Lindsey Strang Aberg
- Maryanne Magnier
- Tasneem U. Chowdhury
- Tomasz Mielniczuk
- Jason S. Wasserman
About Axinn
Axinn combines the skills, experience, and dedication of the world’s largest firms with the focus, responsiveness, efficiency, and attention to client needs of the best boutiques. The firm was established in the late 1990s by lawyers from premier Wall Street firms with a common vision: provide the highest level of service and strategic acumen in antitrust, intellectual property, and high-stakes litigation. Axinn’s lawyers have served as lead or co-lead counsel on more than half a trillion dollars in transactions and, in the last 10 years alone, have handled more than 500 litigations.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
NJSBA Annual Meeting and Convention 2025
Speaking Engagement
Intellectual Property
CompLaw Antitrust West Coast Conference 2025
Speaking Engagement
Antitrust
AHLA Health Care Transactions Program 2025
Sponsorship
Antitrust
ACI 21st Annual Paragraph IV Conference
Speaking Engagement
Intellectual Property
ABA 73rd Annual Section of Antitrust Law Spring Meeting
Speaking Engagement
Antitrust
AIPLA CLE Web Series: Hot Topics in Chemical & Biotech Patent Practice
Speaking Engagement
17th Annual Practitioners' Think Tank on ITC Litigation & Enforcement
Speaking Engagement
Intellectual Property
Antitrust Enforcement Trends and Policies in 2025: Unfair Competition, Merger Policies, Premerger Procedures
Webinar
Antitrust
CompLaw Nordic 2025
Speaking Engagement
Antitrust
Compounding Problems: Recent Decisions on Tirzepatide Highlight Interplay Between FDA Anti-Compounding Enforcement and Private Intellectual Property Rights
Axinn Viewpoints
Intellectual Property